Our writing contest starts with 10 students, who are eliminated one at a time based on your votes and YP editors’ picks.

The UK’s Medicines and Healthcare Regulatory Agency (MHRA) approved Casgevy for sickle cell disease in 2023, followed by ...

Results prove that inversions can be generated in plants without causing further unwanted changes in the expression of genetic information.

Fintel reports that on January 27, 2025, Morgan Stanley downgraded their outlook for Intellia Therapeutics (NasdaqGM:NTLA) from Overweight to Equal-Weight. Analyst Price Forecast Suggests 449.14% ...

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

The HAELO trial will assess the therapy’s safety and efficacy in 60 adult subjects with Type I or Type II HAE.

New study reveals that TLE6 protein deficiency causes male infertility in mice. These findings suggest potential genetic ...

It feels fantastic,” said Blau, who thanked her lab members and colleagues for their support and dedication. “This achievement is a reflection of our collective efforts and ...

CRISPR-Cas9 is one of the biggest discoveries of the 21st century. Since it was developed in 2012, this gene-editing tool has revolutionized biology research, making it easier to study disease and ...

Trusted by leading innovators worldwide, ERS Genomics is committed to providing responsible and effective access to CRISPR/Cas9 technology. To support small and early-stage organizations ...

A genome-wide CRISPR/Cas9 screen identifies VLDLR as entry receptor for SFV4. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-55493-3 ...